Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3652-3655

  Huber, Charlotte A ^a   McOdimba, Francis ^c   Pflueger, Valentin ^b   Daubenberger, Claudia A ^a   Revathi, Gunturu ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b MABRITEC AG   (Switzerland)

^c AGA KHAN UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; PENICILLIN G;

AFRICA; AFRICAN AMERICAN; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; COMORBIDITY; CONTROLLED STUDY; CULTURE MEDIUM; GENE AMPLIFICATION; GROUP B STREPTOCOCCAL INFECTION; HOUSEKEEPING GENE; HUMAN; MULTILOCUS SEQUENCE TYPING; NEUROGENIC BLADDER; NONSPECIFIC URETHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PYURIA; SEROTYPE; STREPTOCOCCUS AGALACTIAE; URINALYSIS; URINARY TRACT INFECTION; VAGINA SMEAR;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; HUMANS; KENYA; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PREGNANCY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE;

EID: 80053492520     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01288-11     Document Type: Article

References (27)

1. Bisharat, N., et al. 2005. Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. Microbiology (Reading, Engl.). 151:1875-1881.
2. Blancas, D., et al. 2004. Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 23:168-173. (Pubitemid 38471421)
3. Bohnsack, J. F., et al. 2008. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. academic centers from 1995 to 1999. J. Clin. Microbiol. 46:1285-1291. (Pubitemid 351563569)
4. Brochet, M., E. Couvé, R. Bercion, J.-M. Sire, and P. Glaser. 2009. Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui. J. Clin. Microbiol. 47:800-803.
5. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Corvec, S., et al. 2011. Clinical features of group B Streptococcus prosthetic joint infections and molecular characterization of isolates. J. Clin. Microbiol. 49:380-382.
7. Edwards, M. S., and C. J. Baker. 2005. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41:839-847. (Pubitemid 41266752)
8. Farley, M. M., et al. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811. (Pubitemid 23174711)
9. Gherardi, G., et al. 2007. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol. 45:2909-2916. (Pubitemid 47421999)
10. Imperi, M., et al. 2010. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J. Microbiol. Methods 80:212-214.
11. Jolley, K. A., E. J. Feil, M. S. Chan, and M. C. Maiden. 2001. Sequence type analysis and recombinational tests (START). Bioinformatics 17:1230-1231. (Pubitemid 33735352)
12. Jolley, K., M.-S. Chan, and M. Maiden. 2004. mlstdbNet - distributed multilocus sequence typing (MLST) databases. BMC Bioinformatics 5:86.
13. Jones, N., et al. 2003. Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41:2530-2536. (Pubitemid 36712464)
14. Jones, N., et al. 2006. Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. Clin. Infect. Dis. 42:915-924.
15. Koenig, J. M., and W. J. Keenan. 2009. Group B streptococcus and earlyonset sepsis in the era of maternal prophylaxis. Pediatr. Clin. North Am. 56:689-708.
16. Lefevre, J. C., J. P. Lepargneur, R. Bauriaud, M. A. Bertrand, and C. Blanc. 1991. Clinical and microbiologic features of urethritis in men in Toulouse, France. Sex. Transm. Dis. 18:76-79.
17. Luan, S.-L., et al. 2005. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43:3727-3733. (Pubitemid 41129652)
18. Phares, C. R., et al. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065. (Pubitemid 351656587)
19. Schrag, S. J., et al. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20. (Pubitemid 30020655)
20. Schuchat, A. 1999. Group B streptococcus. Lancet 353:51-56. (Pubitemid 29037712)
21. Schwartz, B., et al. 1991. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 266:1112-1114.
22. Sendi, P., L. Johansson, and A. Norrby-Teglund. 2008. Invasive group B streptococcal disease in non-pregnant adults. Infection 36:100-111.
23. Skoff, T. H., et al. 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin. Infect. Dis. 49:85-92.
24. Sørensen, U. B. S., K. Poulsen, C. Ghezzo, I. Margarit, and M. Kilian. 2010. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio 1:e00178-10.
25. Valkenburg-van den Berg, A. W., et al. 2010. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol. Obstet. Invest. 69:174-183.
26. Van der Mee-Marquet, N., et al. 2008. Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J. Clin. Microbiol. 46:2906-2911.
27. Verani, J. R., L. McGee, and S. J. Schrag. 2010. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm. Rep. 59:1-36.